Monoflu 800 Tablet

Introduction

Monoflu is a prescription medication that contains the active ingredient Favipiravir. It is available in tablet form and is used for the treatment of certain viral infections.

Uses

Monoflu is primarily prescribed for the treatment of influenza (flu) caused by the influenza virus. It may also be used for the treatment of other viral respiratory tract infections.

Dosage and Administration

The dosage of Monoflu may vary depending on the age, weight, and medical condition of the patient. Follow the instructions provided by your healthcare professional. Generally, the recommended dosage for adults is 1600 mg (four tablets of 400 mg) as an initial dose, followed by 600 mg (two tablets of 300 mg) twice a day for the duration of the treatment. The tablets should be taken with food to improve absorption.

Mechanism of Action

Favipiravir, the active ingredient in Monoflu, works by inhibiting the replication of the influenza virus. It does this by selectively targeting the viral RNA-dependent RNA polymerase, an enzyme essential for viral replication. By inhibiting this enzyme, Favipiravir helps to reduce the viral load and shorten the duration of the infection.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, and headache. These side effects are generally mild and transient.

Serious side effects are rare but may include allergic reactions, such as rash, itching, swelling, or difficulty breathing. If you experience any serious side effects, seek immediate medical attention.

Drug Interactions

Monoflu may interact with certain medications, including antacids, iron supplements, and certain antiviral drugs. Inform your healthcare professional about all the medications you are currently taking to avoid any potential drug interactions.

Precautions

Before taking Monoflu, inform your healthcare professional about any allergies you may have, as well as any other medical conditions you have, especially kidney or liver problems. This medication should be used with caution in pregnant women, as its safety during pregnancy has not been established.

Monoflu is not recommended for use in children under the age of 18, as its safety and efficacy in this population have not been established.

Storage

Monoflu should be stored in a cool, dry place away from direct sunlight. It should be kept out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Monoflu exactly as prescribed by your healthcare professional. Do not take more or less than the recommended dosage.
• complete the full course of treatment, even if you start feeling better before the treatment is completed.
• If you experience any side effects or have any concerns while taking Monoflu, speak to your healthcare professional.
• Avoid taking antacids, iron supplements, or other medications that may interact with Monoflu without consulting your healthcare professional.
• Store the medication in a safe place and follow the storage instructions provided.
• If you have any questions or need further information about Monoflu, consult your healthcare professional.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Favipiravir use while Breastfeeding (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• LactMed: Drugs and Lactation Database (National Library of Medicine) [Accessed 21 Jun. 2024] (online) Available at:
• Ghasemnejad-Berenji M, Pashapour S. Favipiravir and COVID-19: A Simplified Summary. Drug Res (Stuttg). 2021 Mar;71(3):166-170. doi: 10.1055/a-1296-7935. Epub 2020 Nov 11. [Accessed 5 Jun. 2024] Available at:
• Korula P, Alexander H, John JS, Kirubakaran R, Singh B, Tharyan P, Rupali P. Favipiravir for treating COVID-19. Cochrane Database Syst Rev. 2024 Feb 5;2(2):CD015219. doi: 10.1002/14651858.CD015219.pub2. [Accessed 25 Jun. 2024] Available at: